How Cancer Cells Change When They Leave Original Site
A study by researchers at Weill Cornell Medical College reveals the vital steps cancer cells undertake after they convert themselves in order to detach from a tumor and metastasize. The study published online and in the upcoming issue of Cancer Research, highlights how cancer cells reverse the process, and switch back into classical cancer that can evolve into a new tumor. The research was funded by a grant to the Cornell Center on the Microenvironment and Metastasis and the Neuberger Berman Foundation from the National Cancer Institute.
Why Does Cancer Progress? Study Provides Insight
According to the University of Kentucky, a study funded by a National Cancer Institute research grant and conducted by Dr. Daret St. Clair, the James Graham Brown Endowed Chair and professor of toxicology, provides new understanding into the association between two types of suppressors in cancerous tumors. Results from the study will help researchers to better understand transcriptional mechanisms in carcinogenesis. The study was recently published in Cancer Research. The researchers produced transgenic mice expressing a luciferase reporter gene controlled by human manganese superoxide dismutase (MnSOD) promoter-enhancer elements.
Disparities In Kidney Transplantation May Be Reduced By Patient Education Classes
Being educated about your health and your treatment options is a good thing. According to a new study, kidney failure patients who take part in an education program are more likely to get evaluated for a kidney transplant. The study appears in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that requiring a formal patient education class may help reduce inequities in kidney failure patients' access to kidney transplantation. Kidney transplantation is the preferred treatment for kidney failure.